Researchers assess how disease type, comorbidities, and treatment knowledge shape clinical outcomes and healthcare use in patients with chronic urticaria.
New trial finds a 16% relative risk reduction in atopic dermatitis with full-body emollient use starting in early infancy—especially effective in low-risk infants and dog-owning households.
Topical delgocitinib improved eczema severity scores and caused fewer adverse events than oral alitretinoin in adults with severe chronic hand eczema, according to a phase 3 study.
A recent study investigated the prevalence of allergies and asthma among U.S. children during and before the COVID-19 pandemic, revealing changes in allergy prevalence and potential associations with pandemic-related lifestyle changes.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
A case-control study of 170 biopsied dermatitis cases found that Langerhans cell collections were significantly more common in allergic contact dermatitis than in nonallergic cases.
NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.
A pooled analysis of two phase 3 trials found that a once-daily topical anticholinergic gel significantly improved sweat reduction and symptom severity in patients with axillary hyperhidrosis, with a tolerable safety profile.
COVID-19 infection significantly increases autoimmune blistering disease risk, while vaccination appears protective, researchers report in a study analyzing 112 million patient records